DE68924549D1 - 2- und 4-substituierte 1,3-Dioxolane, deren Synthese und Verwendung. - Google Patents
2- und 4-substituierte 1,3-Dioxolane, deren Synthese und Verwendung.Info
- Publication number
- DE68924549D1 DE68924549D1 DE68924549T DE68924549T DE68924549D1 DE 68924549 D1 DE68924549 D1 DE 68924549D1 DE 68924549 T DE68924549 T DE 68924549T DE 68924549 T DE68924549 T DE 68924549T DE 68924549 D1 DE68924549 D1 DE 68924549D1
- Authority
- DE
- Germany
- Prior art keywords
- substituted
- dioxolanes
- synthesis
- particularly useful
- antiviral agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Secondary Cells (AREA)
- Peptides Or Proteins (AREA)
- Furan Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Paints Or Removers (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17961588A | 1988-04-11 | 1988-04-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68924549D1 true DE68924549D1 (de) | 1995-11-23 |
DE68924549T2 DE68924549T2 (de) | 1996-04-04 |
Family
ID=22657287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68924549T Expired - Lifetime DE68924549T2 (de) | 1988-04-11 | 1989-04-11 | 2- und 4-substituierte 1,3-Dioxolane, deren Synthese und Verwendung. |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0337713B1 (de) |
JP (1) | JP3085675B2 (de) |
KR (1) | KR0137023B1 (de) |
AT (1) | ATE129247T1 (de) |
AU (1) | AU631786B2 (de) |
CA (1) | CA1339609C (de) |
DE (1) | DE68924549T2 (de) |
DK (1) | DK175372B1 (de) |
ES (1) | ES2078234T3 (de) |
GR (1) | GR3017812T3 (de) |
HK (1) | HK5996A (de) |
IE (1) | IE71225B1 (de) |
IL (1) | IL89921A (de) |
NZ (1) | NZ228645A (de) |
OA (1) | OA09470A (de) |
ZA (1) | ZA892645B (de) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5597824A (en) * | 1987-11-03 | 1997-01-28 | Abbott Laboratories | Analogs of oxetanyl purines and pyrimidines |
US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
US6350753B1 (en) | 1988-04-11 | 2002-02-26 | Biochem Pharma Inc. | 2-Substituted-4-substituted-1,3-dioxolanes and use thereof |
US5270315A (en) * | 1988-04-11 | 1993-12-14 | Biochem Pharma Inc. | 4-(purinyl bases)-substituted-1,3-dioxlanes |
US6903224B2 (en) | 1988-04-11 | 2005-06-07 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes |
US5466806A (en) * | 1989-02-08 | 1995-11-14 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
US5684164A (en) * | 1988-04-11 | 1997-11-04 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
US5041449A (en) * | 1988-04-11 | 1991-08-20 | Iaf Biochem International, Inc. | 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections |
US7119202B1 (en) | 1989-02-08 | 2006-10-10 | Glaxo Wellcome Inc. | Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties |
UA45942A (uk) * | 1989-02-08 | 2002-05-15 | Біокем Фарма, Інк. | 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція |
IE904378A1 (en) | 1989-12-20 | 1991-07-03 | Abbott Lab | Analogs of oxetanyl purines and pyrimidines |
US5728575A (en) * | 1990-02-01 | 1998-03-17 | Emory University | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
US6642245B1 (en) | 1990-02-01 | 2003-11-04 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
US6703396B1 (en) | 1990-02-01 | 2004-03-09 | Emory University | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers |
GB9009861D0 (en) | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
JP2960164B2 (ja) * | 1990-11-13 | 1999-10-06 | バイオケム ファーマ インコーポレイテッド | 抗ウイルス特性を有する置換1,3−オキサチオラン類および置換1,3−ジチオラン類 |
US6228860B1 (en) | 1990-11-13 | 2001-05-08 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes with antiviral properties |
US6369066B1 (en) | 1990-11-13 | 2002-04-09 | Biochem Pharma, Inc. | Substituted 1,3-oxathiolanes with antiviral properties |
US5587480A (en) * | 1990-11-13 | 1996-12-24 | Biochem Pharma, Inc. | Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |
US5248776A (en) * | 1990-12-05 | 1993-09-28 | University Of Georgia Research Foundation, Inc. | Process for enantiomerically pure β-L-1,3-oxathiolane nucleosides |
US5179104A (en) | 1990-12-05 | 1993-01-12 | University Of Georgia Research Foundation, Inc. | Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides |
US5925643A (en) * | 1990-12-05 | 1999-07-20 | Emory University | Enantiomerically pure β-D-dioxolane-nucleosides |
US5444063A (en) * | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
US6812233B1 (en) | 1991-03-06 | 2004-11-02 | Emory University | Therapeutic nucleosides |
GB9104740D0 (en) * | 1991-03-06 | 1991-04-17 | Wellcome Found | Antiviral nucleoside combination |
US5817667A (en) * | 1991-04-17 | 1998-10-06 | University Of Georgia Research Foudation | Compounds and methods for the treatment of cancer |
ZA923641B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
GB9226879D0 (en) * | 1992-12-23 | 1993-02-17 | Iaf Biochem Int | Anti-viral compounds |
US6005107A (en) * | 1992-12-23 | 1999-12-21 | Biochem Pharma, Inc. | Antiviral compounds |
US6444656B1 (en) | 1992-12-23 | 2002-09-03 | Biochem Pharma, Inc. | Antiviral phosphonate nucleotides |
US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
AU7954694A (en) | 1993-09-10 | 1995-03-27 | Centre National De La Recherche Scientifique (Cnrs) | Nucleosides with anti-hepatitis b virus activity |
US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
IL115156A (en) * | 1994-09-06 | 2000-07-16 | Univ Georgia | Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines |
US5703058A (en) * | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
US5808040A (en) * | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
EP1655033A1 (de) | 1995-06-07 | 2006-05-10 | Emory University | Nucleoside mit anti-hepatitis B virus Wirksamkeit |
US5753789A (en) * | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
US5792773A (en) * | 1996-11-15 | 1998-08-11 | Yale University | L-β-dioxolane uridine analog administration for treating Epstein-Barr virus infection |
US6022876A (en) * | 1996-11-15 | 2000-02-08 | Yale University | L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections |
ATE267198T1 (de) | 1997-03-19 | 2004-06-15 | Univ Emory | Synthese und anti-hiv und anti-hepatitis virus aktivität von 1,3-oxaselenolan nucleosiden |
DK1058686T3 (da) | 1998-02-25 | 2007-03-05 | Univ Emory | 2'-fluornukleosider |
EP1754710A3 (de) | 1998-02-25 | 2007-12-19 | Emory University | 2'-Fluoronukleoside |
KR101208429B1 (ko) | 1998-08-12 | 2012-12-05 | 길리애드 사이언시즈, 인코포레이티드 | 1,3-옥사티올란 뉴클레오시드의 제조 방법 |
US6979561B1 (en) | 1998-10-09 | 2005-12-27 | Gilead Sciences, Inc. | Non-homogeneous systems for the resolution of enantiomeric mixtures |
CN1216893C (zh) | 1998-11-05 | 2005-08-31 | 法国国家科学研究中心 | 具有抗乙型肝炎病毒活性的核苷 |
NZ513094A (en) * | 1998-12-23 | 2004-05-28 | Shire Biochem Inc | Antiviral nucleoside analogues |
DE60042921D1 (de) | 1999-03-29 | 2009-10-22 | Shire Canada Inc | Verwendung von cytidinderivaten zur behandlung von leukämie |
US6653318B1 (en) | 1999-07-21 | 2003-11-25 | Yale University | 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use |
ES2218216T3 (es) * | 1999-09-24 | 2004-11-16 | Shire Biochem Inc. | Analogos de nucleosidos de dioxolano para el tratamiento o la prevencion de infecciones viricas. |
CA2389745C (en) * | 1999-11-04 | 2010-03-23 | Shire Biochem Inc. | Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues |
EP1600451A3 (de) | 1999-11-12 | 2008-09-10 | Pharmasset, Inc. | Herstellung von 2'-Deoxy-L-Nukleoside |
US6436948B1 (en) | 2000-03-03 | 2002-08-20 | University Of Georgia Research Foundation Inc. | Method for the treatment of psoriasis and genital warts |
AU2002212015B2 (en) * | 2000-10-13 | 2007-01-25 | Shire Canada Inc. | Dioxolane analogs for improved inter-cellular delivery |
KR20040002871A (ko) | 2001-03-01 | 2004-01-07 | 트라이앵글 파마슈티칼스 인코포레이티드 | 시스-ftc의 다형 및 기타 결정형 |
DE10335061B4 (de) * | 2003-07-31 | 2005-11-17 | Wacker-Chemie Gmbh | Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten |
CA2554782C (en) | 2004-02-03 | 2013-08-13 | Emory University | Methods to manufacture 1,3-dioxolane nucleosides |
CN102924549A (zh) | 2005-09-26 | 2013-02-13 | 吉利德制药有限责任公司 | 作为抗病毒剂的修饰的4'-核苷 |
US8895531B2 (en) | 2006-03-23 | 2014-11-25 | Rfs Pharma Llc | 2′-fluoronucleoside phosphonates as antiviral agents |
WO2008002676A2 (en) | 2006-06-29 | 2008-01-03 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
ES2842334T3 (es) | 2007-10-20 | 2021-07-13 | Athenex Inc | Composiciones farmacéuticas para modular una cascada de cinasas y métodos de uso de las mismas |
WO2016033164A1 (en) | 2014-08-26 | 2016-03-03 | Enanta Pharmaceuticals, Inc. | Nucleoside and nucleotide derivatives |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL76546A (en) * | 1984-10-12 | 1988-12-30 | Warner Lambert Co | 9-(heteroarylalkyl)-6-purine(thi)one derivatives,their preparation and pharmaceutical compositions containing them |
PT82580B (pt) * | 1985-05-15 | 1989-01-17 | Wellcome Found | Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem |
-
1989
- 1989-04-07 NZ NZ228645A patent/NZ228645A/xx unknown
- 1989-04-10 IE IE113689A patent/IE71225B1/en not_active IP Right Cessation
- 1989-04-10 DK DK198901720A patent/DK175372B1/da not_active IP Right Cessation
- 1989-04-10 CA CA000596218A patent/CA1339609C/en not_active Expired - Lifetime
- 1989-04-11 EP EP89303537A patent/EP0337713B1/de not_active Expired - Lifetime
- 1989-04-11 DE DE68924549T patent/DE68924549T2/de not_active Expired - Lifetime
- 1989-04-11 ES ES89303537T patent/ES2078234T3/es not_active Expired - Lifetime
- 1989-04-11 AU AU32644/89A patent/AU631786B2/en not_active Expired
- 1989-04-11 OA OA59557A patent/OA09470A/xx unknown
- 1989-04-11 JP JP01089893A patent/JP3085675B2/ja not_active Expired - Lifetime
- 1989-04-11 IL IL89921A patent/IL89921A/xx unknown
- 1989-04-11 KR KR1019890004725A patent/KR0137023B1/ko not_active IP Right Cessation
- 1989-04-11 AT AT89303537T patent/ATE129247T1/de not_active IP Right Cessation
- 1989-04-11 ZA ZA892645A patent/ZA892645B/xx unknown
-
1995
- 1995-10-19 GR GR950401393T patent/GR3017812T3/el unknown
-
1996
- 1996-01-11 HK HK5996A patent/HK5996A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0337713A2 (de) | 1989-10-18 |
EP0337713A3 (en) | 1990-11-22 |
AU3264489A (en) | 1989-10-12 |
DE68924549T2 (de) | 1996-04-04 |
ZA892645B (en) | 1989-12-27 |
ES2078234T3 (es) | 1995-12-16 |
DK172089A (da) | 1989-10-12 |
NZ228645A (en) | 1991-09-25 |
KR0137023B1 (ko) | 1998-04-25 |
IL89921A (en) | 1993-08-18 |
KR890016046A (ko) | 1989-11-28 |
OA09470A (en) | 1992-11-15 |
HK5996A (en) | 1996-01-19 |
EP0337713B1 (de) | 1995-10-18 |
DK175372B1 (da) | 2004-09-13 |
GR3017812T3 (en) | 1996-01-31 |
DK172089D0 (da) | 1989-04-10 |
IE891136L (en) | 1989-10-11 |
IE71225B1 (en) | 1997-02-12 |
IL89921A0 (en) | 1989-12-15 |
ATE129247T1 (de) | 1995-11-15 |
JP3085675B2 (ja) | 2000-09-11 |
AU631786B2 (en) | 1992-12-10 |
CA1339609C (en) | 1997-12-30 |
JPH01316375A (ja) | 1989-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68924549D1 (de) | 2- und 4-substituierte 1,3-Dioxolane, deren Synthese und Verwendung. | |
ATE126517T1 (de) | Verwendung von bis(3,4- dialkylbenzyliden)sorbitolacetale und diese enthaltende zusammensetzungen. | |
FI906045A0 (fi) | Kvaevehaltiga spirocykliska foereningar. | |
DE3871751D1 (de) | Gelbildende organosiloxanzusammensetzungen und deren verwendung. | |
FI915920A (fi) | Serotoninantagonister. | |
DE68929060D1 (de) | Synthese von 1,2-Dioxetanen und Zwischenprodukte dafür | |
ATE92067T1 (de) | 6-substituierte purinylpiperazinderivate. | |
DE3853711D1 (de) | Zwischenverbindungen für die Synthese von 5,6,7,8-Tetrahydro-L-erythro-biopterin und seiner Derivate. | |
DK0411733T3 (da) | 11-beta-aryl-gona-4,9-dien-3-oner | |
DE3586114D1 (de) | Synthese von ammoniak. | |
DE69517443T2 (de) | Synthese von bis(2,2-dinitropropyl)acetal | |
DE3581843D1 (de) | Metallophosphoaluminate und deren synthese. | |
DK354185D0 (da) | 1,3-dioxolanderivater | |
ES2073495T3 (es) | Benzotiazepinas. | |
DE3586143D1 (de) | Synthese von zeolithischem material. | |
DE69316309T2 (de) | Phenylborinsäure-Derivate, ihre Herstellung und ihre Verwendung als Zwischenprodukte bei der Synthese | |
NO177566C (no) | Nye 1,3-dioksan-derivater | |
ATE61026T1 (de) | Metallophosphoaluminate und deren synthese. | |
DE69111209D1 (de) | Herstellung und Reinigung von 3,4-Dihydrocumarin. | |
SU1557961A1 (ru) | П-хлорфениламид 3-дифенилметил-4-(п-хлорфенил)-2,4-диоксобутановой кислоты, проявляющий противогипоксическую активность | |
ATE27695T1 (de) | Chlorierte abkoemmlinge von hexadecen, deren herstellung und deren anwendung in der synthese von vitamin e. | |
ITMI930040A0 (it) | Derivati di s,s'-bis(carbossammidofenil)-disolfuro ad attivita' cardiovascolare | |
FI873000A (fi) | Substituoituja 1,2,3-tiadiatsoli-4-tiolaatteja | |
KR860003626U (ko) | 타자기의 캐리지 높이 조절 장치 | |
IT8819944A0 (it) | Sintesi elettrochimica di 2 arilidrochinoni. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: SHIRE BIOCHEM INC., ST.LAURENT, QUEBEC, CA |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: SHIRE CANADA INC., ST. LAURENT, QUEBEC, CA |